SecBot SecBot
6-K ·Filed Apr 16, 2026

EVAX

Evaxion A/S
NEUTRAL
Impact 3/10
Horizonmonths Processed7mo ago SEC0001171843-26-002509
Notable filing: 6-K
Actionable Insight • Neutral

No immediate trading implications. Investors should await upcoming clinical or financial updates for material developments.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.14
T+0 close · Apr 16, 2026 · via day close
Latest settled
−27.05%
T+60 · $3.02
Vs SPY
−34.10%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 16 $4.14entry
  2. T+1 · 7mo ago +7.49%α +6.27% · $4.45
  3. T+5 · 7mo ago +2.66%α +1.67% · $4.25
  4. T+20 · 6mo ago +0.48%α −5.33% · $4.16
  5. T+60 · 4mo ago −27.05%α −34.10% · $3.02
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Evaxion A/S held its Annual General Meeting on April 16, 2026, approved the 2025 Annual Report, and re-elected four directors while electing one new board member. This is a routine corporate governance update with no material financial implications.

Key Facts

  • Annual General Meeting held on April 16, 2026
  • 2025 Annual Report approved
  • Marianne Sgaard, Lars Holtug, Lars Aage Staal Wegner, and Roberto Prego Pineda re-elected to Board of Directors
  • Jens Bitsch Nrhave elected as new Board member

Financial Impact

No financial impact disclosed

Risk Factors

  • Board composition changes could influence strategic direction over time
  • No new financial or operational data provided in this filing

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-002509
Exhibit: exh_991.htm0001171843-26-002509
Document: 0001171843-26-002509-index-headers.html0001171843-26-002509
Document: 0001171843-26-002509-index.html0001171843-26-002509
Document: 0001171843-26-002509.txt0001171843-26-002509

Track record

50 reports on EVAX

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +22.94% at T+5 after the Mar 5, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  2. Nov 12, 20264d ago Press Release Neutral 1/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  3. Nov 9, 20267d ago 6-K / F-1/A / PRESS-RELEASE Neutral 3/10 Entry $2.75 to $2.86 Now $2.77 +0.73% ▲ +4.00% +4.37% vs SPY
  4. Nov 6, 202610d ago 6-K Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  5. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  6. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  7. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  8. Nov 3, 202613d ago 6-K Neutral 4/10 Entry $2.96 to $2.97 Now $2.77 −6.42% ▲ +0.34% −1.31% vs SPY
  9. Oct 30, 202617d ago 6-K Neutral 2/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
  10. Oct 30, 202617d ago Press Release Neutral 3/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
Showing 10 of 50

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 16, 2026